Company Overview

Update
Headquarters:
Cambridge, MA
Funding:
$47M
Categories:
Biotechnology

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

Description

Update

Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patients’ quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.

Current Team (6)

Update

Funding Rounds (1) - $47M

Update

Investors (1)

Update
  • 9f2b8ed799c4cab313f6ad0a4fb88958

    Third Rock Ventures

    Third Rock Ventures invests in transformational life science companies that show high growth..

Offices/Locations (1)

Update
  • Office

    1030 Massachusetts Avenue

    Cambridge, MA 02138

    USA